Gregg C Fonarow

Summary

Affiliation: University of California
Country: USA

Publications

  1. Fonarow G, Smith E, Saver J, Reeves M, Hernandez A, Peterson E, et al. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. Stroke. 2011;42:2983-9 pubmed publisher
    ....
  2. request reprint
    Fonarow G. Improving quality of care and outcomes for heart failure. -Role of registries-. Circ J. 2011;75:1783-90 pubmed
    ....
  3. Pandey A, Golwala H, DeVore A, Lu D, Madden G, Bhatt D, et al. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program. JACC Heart Fail. 2016;4:649-61 pubmed publisher
    ..Unlike patients with normal renal function, there was no significant change in 1-year clinical outcomes over time among HF patients on dialysis. ..
  4. Fonarow G, Albert N, Curtis A, Stough W, Gheorghiade M, Heywood J, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010;122:585-96 pubmed publisher
    ..URL: http://www.clinicaltrials.gov. Unique identifier: NCT00303979. ..
  5. Fonarow G, Smith E, Saver J, Reeves M, Bhatt D, Grau Sepulveda M, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011;123:750-8 pubmed publisher
    ..5 years. These findings support the need for a targeted initiative to improve the timeliness of reperfusion in acute ischemic stroke. ..
  6. Ziaeian B, Kominski G, Ong M, Mays V, Brook R, Fonarow G. National Differences in Trends for Heart Failure Hospitalizations by Sex and Race/Ethnicity. Circ Cardiovasc Qual Outcomes. 2017;10: pubmed publisher
    ..An evaluation of factors explaining the improvements in the HF hospitalization rates among Hispanics and Asian/Pacific Islanders is needed. ..
  7. Pandey A, Kim S, Moore C, Thomas L, Gersh B, Allen L, et al. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation. JACC Heart Fail. 2017;5:44-52 pubmed publisher
    ..Traditional HF risk factors, AF type, and baseline heart rate are independent clinical predictors of incident HF. ..
  8. Khera R, Pandey A, Kumar N, Singh R, Bano S, Golwala H, et al. Variation in Hospital Use and Outcomes Associated With Pulmonary Artery Catheterization in Heart Failure in the United States. Circ Heart Fail. 2016;9: pubmed
    ..This is accompanied by a decline in excess mortality associated with PA catheterization. ..
  9. Patel D, Shah R, Bhatt D, Liang L, Schulte P, DeVore A, et al. Guideline-Appropriate Care and In-Hospital Outcomes in Patients With Heart Failure in Teaching and Nonteaching Hospitals: Findings From Get With The Guidelines-Heart Failure. Circ Cardiovasc Qual Outcomes. 2016;9:757-766 pubmed publisher
    ..07). Data from the GWTG-HF program suggest that there was improving and comparable adherence with HF performance measures and use of guideline-recommended therapies irrespective of hospital teaching status. ..
  10. Pandey A, Golwala H, Xu H, DeVore A, Matsouaka R, Pencina M, et al. Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes. JACC Heart Fail. 2016;4:935-946 pubmed publisher
    ..These findings raise questions about the validity of the HRRP performance metric in identifying and penalizing low-performance centers. ..

Locale

Detail Information

Publications25

  1. Fonarow G, Smith E, Saver J, Reeves M, Hernandez A, Peterson E, et al. Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. Stroke. 2011;42:2983-9 pubmed publisher
    ....
  2. request reprint
    Fonarow G. Improving quality of care and outcomes for heart failure. -Role of registries-. Circ J. 2011;75:1783-90 pubmed
    ....
  3. Pandey A, Golwala H, DeVore A, Lu D, Madden G, Bhatt D, et al. Trends in the Use of Guideline-Directed Therapies Among Dialysis Patients Hospitalized With Systolic Heart Failure: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program. JACC Heart Fail. 2016;4:649-61 pubmed publisher
    ..Unlike patients with normal renal function, there was no significant change in 1-year clinical outcomes over time among HF patients on dialysis. ..
  4. Fonarow G, Albert N, Curtis A, Stough W, Gheorghiade M, Heywood J, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation. 2010;122:585-96 pubmed publisher
    ..URL: http://www.clinicaltrials.gov. Unique identifier: NCT00303979. ..
  5. Fonarow G, Smith E, Saver J, Reeves M, Bhatt D, Grau Sepulveda M, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011;123:750-8 pubmed publisher
    ..5 years. These findings support the need for a targeted initiative to improve the timeliness of reperfusion in acute ischemic stroke. ..
  6. Ziaeian B, Kominski G, Ong M, Mays V, Brook R, Fonarow G. National Differences in Trends for Heart Failure Hospitalizations by Sex and Race/Ethnicity. Circ Cardiovasc Qual Outcomes. 2017;10: pubmed publisher
    ..An evaluation of factors explaining the improvements in the HF hospitalization rates among Hispanics and Asian/Pacific Islanders is needed. ..
  7. Pandey A, Kim S, Moore C, Thomas L, Gersh B, Allen L, et al. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation. JACC Heart Fail. 2017;5:44-52 pubmed publisher
    ..Traditional HF risk factors, AF type, and baseline heart rate are independent clinical predictors of incident HF. ..
  8. Khera R, Pandey A, Kumar N, Singh R, Bano S, Golwala H, et al. Variation in Hospital Use and Outcomes Associated With Pulmonary Artery Catheterization in Heart Failure in the United States. Circ Heart Fail. 2016;9: pubmed
    ..This is accompanied by a decline in excess mortality associated with PA catheterization. ..
  9. Patel D, Shah R, Bhatt D, Liang L, Schulte P, DeVore A, et al. Guideline-Appropriate Care and In-Hospital Outcomes in Patients With Heart Failure in Teaching and Nonteaching Hospitals: Findings From Get With The Guidelines-Heart Failure. Circ Cardiovasc Qual Outcomes. 2016;9:757-766 pubmed publisher
    ..07). Data from the GWTG-HF program suggest that there was improving and comparable adherence with HF performance measures and use of guideline-recommended therapies irrespective of hospital teaching status. ..
  10. Pandey A, Golwala H, Xu H, DeVore A, Matsouaka R, Pencina M, et al. Association of 30-Day Readmission Metric for Heart Failure Under the Hospital Readmissions Reduction Program With Quality of Care and Outcomes. JACC Heart Fail. 2016;4:935-946 pubmed publisher
    ..These findings raise questions about the validity of the HRRP performance metric in identifying and penalizing low-performance centers. ..
  11. Lyons K, Ezekowitz J, Liang L, Heidenreich P, Yancy C, DeVore A, et al. Impact of Current Versus Previous Cardiac Resynchronization Therapy Guidelines on the Proportion of Patients With Heart Failure Eligible for Therapy. JACC Heart Fail. 2017;5:388-392 pubmed publisher
    ..In this population of patients with HF, an LVEF ≤35%, and no documented contraindication for CRT, the current ACCF/AHA HF guidelines reduce the proportion of patients eligible for CRT by approximately 15%. ..
  12. Pokorney S, Kim S, Thomas L, Fonarow G, Kowey P, Gersh B, et al. Cardioversion and subsequent quality of life and natural history of atrial fibrillation. Am Heart J. 2017;185:59-66 pubmed publisher
    ..Many patients who undergo cardioversion do not receive adjunctive rhythm control therapies. These findings may help to better inform therapeutic decision making. ..
  13. Xian Y, Xu H, Lytle B, Blevins J, Peterson E, Hernandez A, et al. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke. Circ Cardiovasc Qual Outcomes. 2017;10: pubmed publisher
    ..Nevertheless, certain strategies were infrequently practiced and represent a potential immediate target for further improvements. ..
  14. Man S, Cox M, Patel P, Smith E, Reeves M, Saver J, et al. Differences in Acute Ischemic Stroke Quality of Care and Outcomes by Primary Stroke Center Certification Organization. Stroke. 2017;48:412-419 pubmed publisher
    ..These findings may have important implications for further improving systems of care. ..
  15. Sutton N, Li S, Thomas L, Wang T, de Lemos J, Enriquez J, et al. The association of left ventricular ejection fraction with clinical outcomes after myocardial infarction: Findings from the Acute Coronary Treatment and Intervention Outcomes Network (ACTION) Registry-Get With the Guidelines (GWTG) Medicare-linked da. Am Heart J. 2016;178:65-73 pubmed publisher
    ..11, 95% CI 1.09-1.12). Low EF after MI remains an important risk factor for postdischarge mortality and hospital readmission, even after adjustment for patient and hospital characteristics. ..
  16. Fonarow G, Liang L, Thomas L, Xian Y, Saver J, Smith E, et al. Assessment of Home-Time After Acute Ischemic Stroke in Medicare Beneficiaries. Stroke. 2016;47:836-42 pubmed publisher
    ..Home-time represents a novel, easily measured, patient-centered, outcome measure for an episode of stroke care. ..
  17. Patel N, Ju C, Macon C, Thadani U, Schulte P, Hernandez A, et al. Temporal Trends of Digoxin Use in Patients Hospitalized With Heart Failure: Analysis From the American Heart Association Get With The Guidelines-Heart Failure Registry. JACC Heart Fail. 2016;4:348-56 pubmed publisher
    ..0001). One in 5 HFrEF patients received digoxin at discharge, with a significant downward temporal trend in use over the study period. Use of digoxin in HFpEF patients without AF was very low and decreased over the study period. ..
  18. Ziaeian B, Heidenreich P, Xu H, DeVore A, Matsouaka R, Hernandez A, et al. Race/Ethnic Differences in Outcomes Among Hospitalized Medicare Patients With Heart Failure and Preserved Ejection Fraction. JACC Heart Fail. 2017;5:483-493 pubmed publisher
    ..These differences in mortality and readmission risk according to race/ethnicity persisted after adjusting for patient characteristics, SES, and hospital factors. ..
  19. DeVore A, Thomas L, Albert N, Butler J, Hernandez A, Patterson J, et al. Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registry. Am Heart J. 2017;189:177-183 pubmed publisher
    ....
  20. Steinberg B, Shrader P, Thomas L, Ansell J, Fonarow G, Gersh B, et al. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Am Heart J. 2017;189:40-47 pubmed publisher
    ..Those selected for NOAC treatment had lower stroke and bleeding risk profiles, were more likely treated by cardiologists, and had higher socioeconomic status. clinicaltrials.gov Identifier: NCT01701817. ..
  21. Fonarow G, Yancy C, Hernandez A, Peterson E, Spertus J, Heidenreich P. Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. Am Heart J. 2011;161:1024-30.e3 pubmed publisher
    ..These data may underscore the importance of performance improvement efforts to translate evidence-based therapy to routine clinical practice so as to reduce contemporary HF mortality. ..
  22. Kim S, Molnar M, Fonarow G, Streja E, Wang J, Gillen D, et al. Mean platelet volume and mortality risk in a national incident hemodialysis cohort. Int J Cardiol. 2016;220:862-70 pubmed publisher
    ..Hemodialysis patients with higher MPV have heightened mortality risk. Further studies are needed to determine the pathophysiologic basis for the higher risk, and if modification of MPV ameliorates mortality in this population. ..
  23. Echouffo Tcheugui J, Shrader P, Thomas L, Gersh B, Kowey P, Mahaffey K, et al. Care Patterns and Outcomes in Atrial Fibrillation Patients With and Without Diabetes: ORBIT-AF Registry. J Am Coll Cardiol. 2017;70:1325-1335 pubmed publisher
    ..Among AF patients, diabetes was associated with worse AF symptoms and lower quality of life, and increased risk of death and hospitalizations, but not thromboembolic or bleeding events. ..
  24. Hsu J, Ziaeian B, Fonarow G. Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions. JACC Heart Fail. 2017;5:763-771 pubmed publisher
    ....
  25. Shah K, Xu H, Matsouaka R, Bhatt D, Heidenreich P, Hernandez A, et al. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. J Am Coll Cardiol. 2017;70:2476-2486 pubmed publisher
    ..These findings underscore the need to improve treatment of patients with HF. ..